Bayesian Capital Management, LP Royalty Pharma PLC Transaction History

Bayesian Capital Management, LP

  • $600 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$26.21 - $29.22 $399,754 - $445,663
15,252 New
15,252 $428,000
Q3 2021

Nov 15, 2021
SELL
$36.14 - $42.24 $697,502 - $815,232
-19,300 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$39.85 - $46.63 $769,105 - $899,959
19,300 New
19,300 $791,000

Others Institutions Holding RPRX

# of Institutions
497
Shares Held
307M
Call Options Held
1.99M
Put Options Held
384K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $15.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email